Source: Prostate Cancer Foundation
From: PR Newswire
Guide Offers Recommendations on Newest Life-Extending Treatments for Men with Metastatic Prostate Cancer and their Families
The Prostate Cancer Foundation, in honor of Prostate Cancer Awareness Month this September, today released the Prostate Cancer Patient Guide, a new, comprehensive health guide for prostate cancer patients, of whom there are estimated to be three million in the United States. The 36-page patient guide, available for download at http://www.pcf.org/
Unlike previous patient resources, the Prostate Cancer Patient Guide is geared not just towards patients and caregivers, but the whole family. It provides helpful in-depth information for navigating a prostate cancer, offering details on the most up-to-date life-extending treatments for men with metastatic prostate cancer. The guide also introduces precision medicine as a tool for curing patients and families across all cancer types.
“PCF research is increasingly revealing the genetic underpinnings of cancer across cancer types,” said Prostate Cancer Foundation President & CEO Jonathan Simons, M.D. “Family members must take the time to understand how genes that run in families can affect their health. This is not just for men – and not just for prostate cancer – but for all men and women and sons and daughters and grandchildren in the family. And it goes across all cancer types.”
The guide is provided for free in both digital and printed copy. Prostate cancer patient and former Washington Post reporter Bill Curry said, “Today’s cancer decision making is an obstacle course. I wish there had been something like this 10 years ago when I was diagnosed: a one-place go-to to foster a meaningful discussion with a doctor. Thanks to the PCF, there’s so much more knowledge out there today to factor in and absorb.”
About the Prostate Cancer Foundation
The Prostate Cancer Foundation (PCF) is the world’s leading philanthropic organization funding and accelerating prostate cancer research. Founded in 1993, PCF has raised more than $700 million and provided funding to more than 2,000 research programs at more than 200 cancer centers and universities. The PCF global research enterprise now extends to 19 countries and funds a robust research portfolio. PCF advocates for greater awareness of prostate cancer and more efficient investment of governmental research funds for transformational cancer research. Its efforts have helped produce a 20-fold increase in government funding for prostate cancer. For more information, visit www.pcf.org.